Download PDF
Semin Thromb Hemost 2015; 41(01): 084-090
DOI: 10.1055/s-0034-1398383
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Hemostatic and Thrombotic Issues in Cardiac Surgery

Marco Ranucci
1   Department of Cardiothoracic and Vascular Anesthesia and Intensive Care, IRCCS Policlinico San Donato, Milan, Italy
› Author Affiliations
Further Information

Publication History

Publication Date:
15 January 2015 (online)

    Permissions and Reprints

Abstract

Cardiac surgery with cardiopulmonary bypass determines a serious imbalance of the hemostatic system. The clinical pattern is multifactorial, involving patient-related, drug-related, and surgery-related factors. As a result, the patient is prone to both hemorrhagic and thrombotic complications. To address the clinical management of a bleeding patient after cardiac surgery, avoiding empirical administration of drugs and blood derivates, it is mandatory to correctly identify the factor(s) responsible for bleeding. Bleeding after cardiac operations can be ascribed to seven basic mechanisms: residual heparin effect; reduced thrombin generation; fibrinogen deficiency; thrombocytopenia; platelet dysfunction; hyperfibrinolysis; and surgical sources. These factors may interact together, creating a complex coagulopathy. Point-of-care coagulation tests are useful to orienteer the clinician in this complex scenario. Viscoelastic coagulation tests find their greater usefulness in the diagnosis of the bleeding mechanism(s), whereas platelet function tests appear more useful for the preoperative assessment of patients under the effects of antiplatelet agents. Thromboembolic complications are the other side of the coin, and their prevention is still a matter of debate. Consumption of natural anticoagulants and endothelial disturbance are important mechanisms underlying this condition. Strategies to limit antithrombin (AT) consumption or to correct low postoperative levels of AT are still a matter of discussion.

Keywords

cardiac surgery - cardiopulmonary bypass - bleeding - transfusions - point-of-care tests
 

  • References

  • 1 Wells AW, Llewelyn CA, Casbard A , et al. The EASTR Study: indications for transfusion and estimates of transfusion recipient numbers in hospitals supplied by the National Blood Service. Transfus Med 2009; 19 (6) 315-328
    CrossrefPubMedGoogle Scholar
  • 2 US Department of Health and Human Services. The 2007 Nationwide Blood Collection and Utilization Survey Report. Washington, DC: Department of Health and Human Services; 2007
    Google Scholar
  • 3 Bakaeen FG, Chu D, Kelly RF, Holman WL, Jessen ME, Ward HB. Perioperative outcomes after on- and off-pump coronary artery bypass grafting. Tex Heart Inst J 2014; 41 (2) 144-151
    PubMedGoogle Scholar
  • 4 Filsoufi F, Rahmanian PB, Castillo JG, Bronster D, Adams DH. Incidence, topography, predictors and long-term survival after stroke in patients undergoing coronary artery bypass grafting. Ann Thorac Surg 2008; 85 (3) 862-870
    CrossrefPubMedGoogle Scholar
  • 5 Sastry P, Hardman G, Page A , et al. Mesenteric ischaemia following cardiac surgery: the influence of intraoperative perfusion parameters. Interact Cardiovasc Thorac Surg 2014; 19 (3) 419-424
    CrossrefPubMedGoogle Scholar
  • 6 Ranucci M, Bozzetti G, Ditta A, Cotza M, Carboni G, Ballotta A. Surgical reexploration after cardiac operations: why a worse outcome?. Ann Thorac Surg 2008; 86 (5) 1557-1562
    CrossrefPubMedGoogle Scholar
  • 7 Ranucci M, Baryshnikova E, Castelvecchio S, Pelissero G ; Surgical and Clinical Outcome Research (SCORE) Group. Major bleeding, transfusions, and anemia: the deadly triad of cardiac surgery. Ann Thorac Surg 2013; 96 (2) 478-485
    CrossrefPubMedGoogle Scholar
  • 8 Murphy GJ, Reeves BC, Rogers CA, Rizvi SI, Culliford L, Angelini GD. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation 2007; 116 (22) 2544-2552
    CrossrefPubMedGoogle Scholar
  • 9 Edmunds Jr LH, Colman RW. Thrombin during cardiopulmonary bypass. Ann Thorac Surg 2006; 82 (6) 2315-2322
    CrossrefPubMedGoogle Scholar
  • 10 Boisclair MD, Lane DA, Philippou H , et al. Mechanisms of thrombin generation during surgery and cardiopulmonary bypass. Blood 1993; 82 (11) 3350-3357
    PubMedGoogle Scholar
  • 11 Chung JH, Gikakis N, Rao AK, Drake TA, Colman RW, Edmunds Jr LH. Pericardial blood activates the extrinsic coagulation pathway during clinical cardiopulmonary bypass. Circulation 1996; 93 (11) 2014-2018
    CrossrefPubMedGoogle Scholar
  • 12 De Somer F, Van Belleghem Y, Caes F , et al. Tissue factor as the main activator of the coagulation system during cardiopulmonary bypass. J Thorac Cardiovasc Surg 2002; 123 (5) 951-958
    CrossrefPubMedGoogle Scholar
  • 13 Albes JM, Stöhr IM, Kaluza M , et al. Physiological coagulation can be maintained in extracorporeal circulation by means of shed blood separation and coating. J Thorac Cardiovasc Surg 2003; 126 (5) 1504-1512
    CrossrefPubMedGoogle Scholar
  • 14 Wippermann J, Albes JM, Hartrumpf M , et al. Comparison of minimally invasive closed circuit extracorporeal circulation with conventional cardiopulmonary bypass and with off-pump technique in CABG patients: selected parameters of coagulation and inflammatory system. Eur J Cardiothorac Surg 2005; 28 (1) 127-132
    CrossrefPubMedGoogle Scholar
  • 15 Ranucci M, Balduini A, Ditta A, Boncilli A, Brozzi S. A systematic review of biocompatible cardiopulmonary bypass circuits and clinical outcome. Ann Thorac Surg 2009; 87 (4) 1311-1319
    CrossrefPubMedGoogle Scholar
  • 16 Ranucci M, Frigiola A, Menicanti L, Ditta A, Boncilli A, Brozzi S. Postoperative antithrombin levels and outcome in cardiac operations. Crit Care Med 2005; 33 (2) 355-360
    CrossrefPubMedGoogle Scholar
  • 17 Boyle Jr EM, Verrier ED, Spiess BD. Endothelial cell injury in cardiovascular surgery: the procoagulant response. Ann Thorac Surg 1996; 62 (5) 1549-1557
    CrossrefPubMedGoogle Scholar
  • 18 Yang L, Vuylsteke A, Gerrard C, Besser M, Baglin T. Postoperative fibrinogen level is associated with postoperative bleeding following cardiothoracic surgery and the effect of fibrinogen replacement therapy remains uncertain. J Thromb Haemost 2013; 11 (8) 1519-1526
    CrossrefPubMedGoogle Scholar
  • 19 Despotis GJ, Santoro SA, Spitznagel E , et al. Prospective evaluation and clinical utility of on-site monitoring of coagulation in patients undergoing cardiac operation. J Thorac Cardiovasc Surg 1994; 107 (1) 271-279
    CrossrefPubMedGoogle Scholar
  • 20 Khan NU, Wayne CK, Barker J, Strang T. The effects of protamine overdose on coagulation parameters as measured by the thrombelastograph. Eur J Anaesthesiol 2010; 27 (7) 624-627
    CrossrefPubMedGoogle Scholar
  • 21 Galeone A, Rotunno C, Guida P , et al. Monitoring incomplete heparin reversal and heparin rebound after cardiac surgery. J Cardiothorac Vasc Anesth 2013; 27 (5) 853-858
    CrossrefPubMedGoogle Scholar
  • 22 Ternström L, Radulovic V, Karlsson M , et al. Plasma activity of individual coagulation factors, hemodilution and blood loss after cardiac surgery: a prospective observational study. Thromb Res 2010; 126 (2) e128-e133
    CrossrefPubMedGoogle Scholar
  • 23 Bosch YP, Al Dieri R, ten Cate H , et al. Measurement of thrombin generation intra-operatively and its association with bleeding tendency after cardiac surgery. Thromb Res 2014; 133 (3) 488-494
    CrossrefPubMedGoogle Scholar
  • 24 Puetz J. Fresh frozen plasma: the most commonly prescribed hemostatic agent. J Thromb Haemost 2013; 11 (10) 1794-1799
    PubMedGoogle Scholar
  • 25 Tanaka KA, Mazzeffi MA, Grube M, Ogawa S, Chen EP. Three-factor prothrombin complex concentrate and hemostasis after high-risk cardiovascular surgery. Transfusion 2013; 53 (4) 920-921
    CrossrefPubMedGoogle Scholar
  • 26 Arnékian V, Camous J, Fattal S, Rézaiguia-Delclaux S, Nottin R, Stéphan F. Use of prothrombin complex concentrate for excessive bleeding after cardiac surgery. Interact Cardiovasc Thorac Surg 2012; 15 (3) 382-389
    CrossrefPubMedGoogle Scholar
  • 27 Gill R, Herbertson M, Vuylsteke A , et al. Safety and efficacy of recombinant activated factor VII: a randomized placebo-controlled trial in the setting of bleeding after cardiac surgery. Circulation 2009; 120 (1) 21-27
    CrossrefPubMedGoogle Scholar
  • 28 Levi M, Peters M, Büller HR. Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding: a systematic review. Crit Care Med 2005; 33 (4) 883-890
    CrossrefPubMedGoogle Scholar
  • 29 Sørensen B, Spahn DR, Innerhofer P, Spannagl M, Rossaint R. Clinical review: Prothrombin complex concentrates—evaluation of safety and thrombogenicity. Crit Care 2011; 15 (1) 201
    CrossrefPubMedGoogle Scholar
  • 30 Kindo M, Hoang Minh T, Gerelli S , et al. Plasma fibrinogen level on admission to the intensive care unit is a powerful predictor of postoperative bleeding after cardiac surgery with cardiopulmonary bypass. Thromb Res 2014; 134 (2) 360-368
    CrossrefPubMedGoogle Scholar
  • 31 Pillai RC, Fraser JF, Ziegenfuss M, Bhaskar B. Influence of circulating levels of fibrinogen and perioperative coagulation parameters on predicting postoperative blood loss in cardiac surgery: a prospective observational study. J Card Surg 2014; 29 (2) 189-195
    CrossrefPubMedGoogle Scholar
  • 32 Faraoni D, Willems A, Savan V, Demanet H, De Ville A, Van der Linden P. Plasma fibrinogen concentration is correlated with postoperative blood loss in children undergoing cardiac surgery. A retrospective review. Eur J Anaesthesiol 2014; 31 (6) 317-326
    CrossrefPubMedGoogle Scholar
  • 33 Shainoff JR, Estafanous FG, Yared JP, DiBello PM, Kottke-Marchant K, Loop FD. Low factor XIIIA levels are associated with increased blood loss after coronary artery bypass grafting. J Thorac Cardiovasc Surg 1994; 108 (3) 437-445
    PubMedGoogle Scholar
  • 34 Blome M, Isgro F, Kiessling AH , et al. Relationship between factor XIII activity, fibrinogen, haemostasis screening tests and postoperative bleeding in cardiopulmonary bypass surgery. Thromb Haemost 2005; 93 (6) 1101-1107
    PubMedGoogle Scholar
  • 35 Kalina U, Stöhr HA, Bickhard H , et al. Rotational thromboelastography for monitoring of fibrinogen concentrate therapy in fibrinogen deficiency. Blood Coagul Fibrinolysis 2008; 19 (8) 777-783
    CrossrefPubMedGoogle Scholar
  • 36 O'Shaughnessy DF, Atterbury C, Bolton Maggs P , et al; British Committee for Standards in Haematology, Blood Transfusion Task Force. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol 2004; 126 (1) 11-28
    CrossrefPubMedGoogle Scholar
  • 37 Rossaint R, Bouillon B, Cerny V , et al; Task Force for Advanced Bleeding Care in Trauma. Management of bleeding following major trauma: an updated European guideline. Crit Care 2010; 14 (2) R52
    CrossrefPubMedGoogle Scholar
  • 38 Rahe-Meyer N. Fibrinogen concentrate in the treatment of severe bleeding after aortic aneurysm graft surgery. Thromb Res 2011; 128 (Suppl. 01) S17-S19
    CrossrefPubMedGoogle Scholar
  • 39 Karlsson M, Ternström L, Hyllner M, Baghaei F, Nilsson S, Jeppsson A. Plasma fibrinogen level, bleeding, and transfusion after on-pump coronary artery bypass grafting surgery: a prospective observational study. Transfusion 2008; 48 (10) 2152-2158
    CrossrefPubMedGoogle Scholar
  • 40 Theusinger OM, Baulig W, Seifert B, Emmert MY, Spahn DR, Asmis LM. Relative concentrations of haemostatic factors and cytokines in solvent/detergent-treated and fresh-frozen plasma. Br J Anaesth 2011; 106 (4) 505-511
    CrossrefPubMedGoogle Scholar
  • 41 Pantanowitz L, Kruskall MS, Uhl L. Cryoprecipitate. Patterns of use. Am J Clin Pathol 2003; 119 (6) 874-881
    CrossrefPubMedGoogle Scholar
  • 42 Ranucci M, Solomon C. Supplementation of fibrinogen in acquired bleeding disorders: experience, evidence, guidelines, and licences. Br J Anaesth 2012; 109 (2) 135-137
    CrossrefPubMedGoogle Scholar
  • 43 Kozek-Langenecker SA, Afshari A, Albaladejo P , et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol 2013; 30 (6) 270-382
    CrossrefPubMedGoogle Scholar
  • 44 Karkouti K, von Heymann C, Jespersen CM , et al. Efficacy and safety of recombinant factor XIII on reducing blood transfusions in cardiac surgery: a randomized, placebo-controlled, multicenter clinical trial. J Thorac Cardiovasc Surg 2013; 146 (4) 927-939
    CrossrefPubMedGoogle Scholar
  • 45 McCall MM, Blackwell MM, Smyre JT , et al. Fresh frozen plasma in the pediatric pump prime: a prospective, randomized trial. Ann Thorac Surg 2004; 77 (3) 983-987, discussion 987
    CrossrefPubMedGoogle Scholar
  • 46 Oliver Jr WC, Beynen FM, Nuttall GA , et al. Blood loss in infants and children for open heart operations: albumin 5% versus fresh-frozen plasma in the prime. Ann Thorac Surg 2003; 75 (5) 1506-1512
    CrossrefPubMedGoogle Scholar
  • 47 Ranucci M, Carlucci C, Isgrò G, Baryshnikova E. A prospective pilot study of platelet function and its relationship with postoperative bleeding in pediatric cardiac surgery. Minerva Anestesiol 2012; 78 (5) 556-563
    PubMedGoogle Scholar
  • 48 Greilich PE, Brouse CF, Beckham J, Jessen ME, Martin EJ, Carr ME. Reductions in platelet contractile force correlate with duration of cardiopulmonary bypass and blood loss in patients undergoing cardiac surgery. Thromb Res 2002; 105 (6) 523-529
    CrossrefPubMedGoogle Scholar
  • 49 Ferraris VA, Brown JR, Despotis GJ , et al; Society of Thoracic Surgeons Blood Conservation Guideline Task Force; Society of Cardiovascular Anesthesiologists Special Task Force on Blood Transfusion; International Consortium for Evidence Based Perfusion. 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg 2011; 91 (3) 944-982
    CrossrefPubMedGoogle Scholar
  • 50 Pickard AS, Becker RC, Schumock GT, Frye CB. Clopidogrel-associated bleeding and related complications in patients undergoing coronary artery bypass grafting. Pharmacotherapy 2008; 28 (3) 376-392
    CrossrefPubMedGoogle Scholar
  • 51 Berger JS, Frye CB, Harshaw Q, Edwards FH, Steinhubl SR, Becker RC. Impact of clopidogrel in patients with acute coronary syndromes requiring coronary artery bypass surgery: a multicenter analysis. J Am Coll Cardiol 2008; 52 (21) 1693-1701
    CrossrefPubMedGoogle Scholar
  • 52 Ferraris VA, Ferraris SP, Saha SP , et al; Society of Thoracic Surgeons Blood Conservation Guideline Task Force; Society of Cardiovascular Anesthesiologists Special Task Force on Blood Transfusion. Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline. Ann Thorac Surg 2007; 83 (5, Suppl): S27-S86
    CrossrefPubMedGoogle Scholar
  • 53 Fitchett D, Eikelboom J, Fremes S , et al. Dual antiplatelet therapy in patients requiring urgent coronary artery bypass grafting surgery: a position statement of the Canadian Cardiovascular Society. Can J Cardiol 2009; 25 (12) 683-689
    CrossrefPubMedGoogle Scholar
  • 54 Ferraris VA, Saha SP, Oestreich JH , et al; Society of Thoracic Surgeons. 2012 update to the Society of Thoracic Surgeons guideline on use of antiplatelet drugs in patients having cardiac and noncardiac operations. Ann Thorac Surg 2012; 94 (5) 1761-1781
    CrossrefPubMedGoogle Scholar
  • 55 Di Dedda U, Ranucci M, Baryshnikova E, Castelvecchio S ; Surgical and Clinical Outcome Research Group. Thienopyridines resistance and recovery of platelet function after discontinuation of thienopyridines in cardiac surgery patients. Eur J Cardiothorac Surg 2014; 45 (1) 165-170
    CrossrefPubMedGoogle Scholar
  • 56 Tantry US, Bonello L, Aradi D , et al; Working Group on On-Treatment Platelet Reactivity. Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding. J Am Coll Cardiol 2013; 62 (24) 2261-2273
    CrossrefPubMedGoogle Scholar
  • 57 Ranucci M, Baryshnikova E, Soro G, Ballotta A, De Benedetti D, Conti D ; Surgical and Clinical Outcome Research (SCORE) Group. Multiple electrode whole-blood aggregometry and bleeding in cardiac surgery patients receiving thienopyridines. Ann Thorac Surg 2011; 91 (1) 123-129
    CrossrefPubMedGoogle Scholar
  • 58 Weber CF, Görlinger K, Meininger D , et al. Point-of-care testing: a prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients. Anesthesiology 2012; 117 (3) 531-547
    CrossrefPubMedGoogle Scholar
  • 59 Steinlechner B, Zeidler P, Base E , et al. Patients with severe aortic valve stenosis and impaired platelet function benefit from preoperative desmopressin infusion. Ann Thorac Surg 2011; 91 (5) 1420-1426
    CrossrefPubMedGoogle Scholar
  • 60 Teufelsbauer H, Proidl S, Havel M, Vukovich T. Early activation of hemostasis during cardiopulmonary bypass: evidence for thrombin mediated hyperfibrinolysis. Thromb Haemost 1992; 68 (3) 250-252
    PubMedGoogle Scholar
  • 61 Royston D, Bidstrup BP, Taylor KM, Sapsford RN. Effect of aprotinin on need for blood transfusion after repeat open-heart surgery. Lancet 1987; 2 (8571) 1289-1291
    PubMedGoogle Scholar
  • 62 Levi M, Cromheecke ME, de Jonge E , et al. Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints. Lancet 1999; 354 (9194) 1940-1947
    CrossrefPubMedGoogle Scholar
  • 63 Mangano DT, Miao Y, Vuylsteke A , et al; Investigators of The Multicenter Study of Perioperative Ischemia Research Group; Ischemia Research and Education Foundation. Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery. JAMA 2007; 297 (5) 471-479
    CrossrefPubMedGoogle Scholar
  • 64 Fergusson DA, Hébert PC, Mazer CD , et al; BART Investigators. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med 2008; 358 (22) 2319-2331
    CrossrefPubMedGoogle Scholar
  • 65 Murkin JM, Falter F, Granton J, Young B, Burt C, Chu M. High-dose tranexamic acid is associated with nonischemic clinical seizures in cardiac surgical patients. Anesth Analg 2010; 110 (2) 350-353
    CrossrefPubMedGoogle Scholar
  • 66 Mangano DT ; Multicenter Study of Perioperative Ischemia Research Group. Aspirin and mortality from coronary bypass surgery. N Engl J Med 2002; 347 (17) 1309-1317
    CrossrefPubMedGoogle Scholar
  • 67 Hill J, Treasure T. Reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in inpatients having surgery: summary of NICE guidance. BMJ 2007; 334 (7602) 1053-1054
    CrossrefPubMedGoogle Scholar
  • 68 Ranucci M, Baryshnikova E, Crapelli GB, Woodward MK, Paez A, Pelissero G. Preoperative antithrombin supplementation in cardiac surgery: a randomized controlled trial. J Thorac Cardiovasc Surg 2013; 145 (5) 1393-1399
    CrossrefPubMedGoogle Scholar